Melior Pharmaceuticals I, Inc. is a biopharmaceutical company based in Exton, Pennsylvania, focused on developing innovative therapies for various medical conditions. The organization specializes in advancing drug candidates through clinical development, particularly in the fields of neurology and psychiatry. By leveraging proprietary technologies and a deep understanding of disease mechanisms, Melior aims to address unmet medical needs and improve patient outcomes through its targeted therapeutic approaches.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#18 in Exton, PA

#854 in Pennsylvania

#23,838 in US

#45,039 in the World

Exton, PA, United States of America

Melior Pharmaceuticals I, Inc.

Forward Citations = 57

7 inventors:

Andrew G Reaume (13 out of 21 patents)

Michael S Saporito (10 out of 18 patents)

Frank L Greenway (3 out of 15 patents)

4. Weina Cong (3 out of 3 patents)

5. Ann Coulter (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Melior Pharmaceuticals I, Inc.. Retrieved from https://idiyas.com/company/melior-pharmaceuticals-i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]